To include your compound in the COVID-19 Resource Center, submit it here.

Oncothyreon completes follow-on

Oncothyreon Inc. (NASDAQ:

Read the full 33 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE